Open Government Portal
Found 10 records similar to COVID-19 viral vector-based vaccines
The purpose of this document is to assist in planning immunization clinics for COVID-19 vaccines during the COVID-19 pandemic.
Pregnancy increases the risk of severe illness from COVID-19. The National Advisory Committee on Immunization (NACI) recommends you get a complete series with an mRNA COVID-19 vaccine if you're pregnant or breastfeeding. Getting the COVID-19 vaccine can prevent serious illness, hospitalization and complications.
Variant strains of SARS-CoV-2 are emerging that may affect the level of protection provided by currently authorized COVID-19 vaccines. As a result, manufacturers are adapting authorized COVID-19 vaccines to provide protection against infection and disease caused by virus variants.
What being vaccinated against COVID-19 means for me. By getting vaccinated, you benefit from the protection you get against COVID-19 and the easing of restrictive measures in your community.
This dataset provides the cumulative number of COVID-19 vaccine doses administered in Canada by jurisdiction, vaccine product, and report date. Variables include:
Jurisdiction ID number
Cumulative number of COVID-19 vaccine doses administered
Cumulative number of Pfizer-BioNTech COVID-19 vaccine doses administered
Cumulative number of Moderna COVID-19 vaccine doses administered
Cumulative number of COVID-19 vaccine (unknown product) doses administered
As of date
For variable definitions, see the data dictionary. For details regarding data sources and limitations, see the technical notes section of the Canadian COVID-19 vaccination coverage report (https://health-infobase.canada.ca/covid-19/vaccination-coverage/technical-notes.html).
The medicine regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the regulatory evidence requirements for COVID-19 vaccine approvals and considerations for post-market pharmacovigilance. This collective statement on COVID-19 vaccines builds on the Consortium's May 2020 pledge to work together to counter the COVID-19 global pandemic.
COVID-19 is a new disease not previously identified in humans. Currently there is no vaccine or therapeutic product for COVID-19 that is authorized to treat or prevent the disease. The outbreak of COVID-19 has resulted in a global review of therapies that could be used to treat or prevent the infection. In an effort to facilitate earlier access to a vaccine, or therapeutic product for COVID-19, the Department will expedite the review of any COVID-19 related health product submissions and applications.
Immunizing all Canadians with COVID-19 vaccine in a timely way will be a major challenge. In support of this massive undertaking, the Public Health Agency of Canada (PHAC) has developed planning guidance for the administration of COVID-19 vaccine.
COVID-19 vaccines are safe and effective. Free vaccines will be available to everyone who lives in Canada over the course of 2021.
Until extensive immunization is achieved, public health measures will continue to be essential to minimize the spread of COVID-19 in Canada and save lives.
The COVID-19 Vaccination Coverage Survey (CVCS) targets all Canadian adults living in the 10 provinces and the capital cities of the 3 territories, except those who live: in institutions or collective dwellings; on-reserve. The purpose of the survey is to measure COVID-19 vaccination coverage in Canada and the provinces and territories. The survey compares vaccination coverage levels by different socio-demographic subgroups. This survey also helps to: find out why some people choose not to get vaccinated; find out if people who are not yet vaccinated against COVID-19 plan to get vaccinated; learn more about people's knowledge, attitudes and beliefs about COVID-19 vaccines and vaccines in general; learn more about trusted sources of information related to COVID-19 vaccines to inform communication efforts.